Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey
Veradigm (OTCMKTS: MDRX) announced the integration of new datasets into its Veradigm Network EHR (VNEHR) Data, one of the largest ambulatory electronic health record databases with over 154 million unique patients. The enhancement includes social determinants of health (SDoH) and mortality data, enabling deeper research insights.
The integration addresses the challenge that 80% of critical patient information is typically locked within unstructured data. Using advanced natural language processing (NLP) technology, VNEHR Data now provides research-ready, de-identified data optimized for life science, public health, and academic research.
The new NLP-derived SDoH data includes socioeconomic, environmental, and behavioral factors such as income levels, education, housing stability, and social support. The mortality data addition aims to enhance real-world evidence generation, support post-market surveillance, and improve drug development through better identification of at-risk populations.
Veradigm (OTCMKTS: MDRX) ha annunciato l'integrazione di nuovi dataset nel suo Veradigm Network EHR (VNEHR) Data, uno dei più grandi database di cartelle cliniche elettroniche ambulatoriali con oltre 154 milioni di pazienti unici. Il miglioramento include i determinanti sociali della salute (SDoH) e i dati di mortalità, consentendo approfondimenti di ricerca più dettagliati.
L'integrazione affronta la sfida che il 80% delle informazioni critiche sui pazienti è tipicamente bloccato in dati non strutturati. Utilizzando una tecnologia avanzata di elaborazione del linguaggio naturale (NLP), i dati VNEHR ora forniscono dati de-identificati pronti per la ricerca, ottimizzati per la scienza della vita, la salute pubblica e la ricerca accademica.
I nuovi dati SDoH derivati da NLP includono fattori socioeconomici, ambientali e comportamentali come i livelli di reddito, l'istruzione, la stabilità abitativa e il supporto sociale. L'aggiunta dei dati di mortalità mira a migliorare la generazione di prove del mondo reale, supportare la sorveglianza post-marketing e migliorare lo sviluppo di farmaci attraverso una migliore identificazione delle popolazioni a rischio.
Veradigm (OTCMKTS: MDRX) anunció la integración de nuevos conjuntos de datos en su Veradigm Network EHR (VNEHR) Data, una de las bases de datos de registros electrónicos de salud ambulatoria más grandes con más de 154 millones de pacientes únicos. La mejora incluye determinantes sociales de la salud (SDoH) y datos de mortalidad, lo que permite obtener perspectivas de investigación más profundas.
La integración aborda el desafío de que el 80% de la información crítica del paciente se encuentra típicamente bloqueada en datos no estructurados. Utilizando tecnología avanzada de procesamiento de lenguaje natural (NLP), los datos de VNEHR ahora proporcionan datos desidentificados listos para la investigación, optimizados para las ciencias de la vida, la salud pública y la investigación académica.
Los nuevos datos SDoH derivados de NLP incluyen factores socioeconómicos, ambientales y de comportamiento, como niveles de ingresos, educación, estabilidad de vivienda y apoyo social. La adición de los datos de mortalidad tiene como objetivo mejorar la generación de evidencia del mundo real, apoyar la vigilancia post-comercialización y mejorar el desarrollo de medicamentos mediante una mejor identificación de las poblaciones en riesgo.
Veradigm (OTCMKTS: MDRX)는 Veradigm Network EHR (VNEHR) 데이터에 새로운 데이터 세트를 통합했다고 발표했습니다. 이는 1억 5400만 명의 독특한 환자를 보유한 가장 큰 외래전자건강기록 데이터베이스 중 하나입니다. 이 향상된 기능은 건강의 사회적 결정요인(SDoH)과 사망 데이터를 포함하여 더 깊은 연구 통찰력을 제공합니다.
이번 통합은 환자 정보의 80%가 일반적으로 비구조화된 데이터에 잠겨 있다는 문제를 해결합니다. 고급 자연어 처리(NLP) 기술을 사용하여 VNEHR 데이터는 이제 생명 과학, 공중 보건 및 학술 연구를 위해 최적화된 연구 준비 완료 비식별 데이터를 제공합니다.
새로운 NLP 기반 SDoH 데이터에는 소득 수준, 교육, 주거 안정성 및 사회적 지원과 같은 사회경제적, 환경적, 행동적 요소가 포함됩니다. 사망 데이터 추가는 실제 세계 증거 생성을 향상시키고, 시장 출시 후 감시를 지원하며, 위험에 처한 인구 집단을 더 잘 식별하여 약물 개발을 개선하려는 목표로 합니다.
Veradigm (OTCMKTS: MDRX) a annoncé l'intégration de nouveaux ensembles de données dans son Veradigm Network EHR (VNEHR) Data, l'une des plus grandes bases de données de dossiers de santé électroniques ambulatoires avec plus de 154 millions de patients uniques. L'amélioration comprend les déterminants sociaux de la santé (SDoH) et les données de mortalité, permettant des aperçus de recherche plus approfondis.
L'intégration aborde le défi selon lequel 80 % des informations critiques sur les patients sont généralement enfermées dans des données non structurées. En utilisant une technologie avancée de traitement du langage naturel (NLP), les données VNEHR offrent désormais des données désidentifiées prêtes pour la recherche, optimisées pour les sciences de la vie, la santé publique et la recherche académique.
Les nouvelles données SDoH dérivées de la NLP incluent des facteurs socio-économiques, environnementaux et comportementaux tels que les niveaux de revenu, l'éducation, la stabilité du logement et le soutien social. L'ajout des données de mortalité vise à améliorer la génération de preuves du monde réel, à soutenir la surveillance post-commercialisation et à améliorer le développement de médicaments grâce à une meilleure identification des populations à risque.
Veradigm (OTCMKTS: MDRX) hat die Integration neuer Datensätze in seine Veradigm Network EHR (VNEHR) Daten angekündigt, eines der größten elektronischen Gesundheitsakten-Datenbanken für ambulante Patienten mit über 154 Millionen einzigartigen Patienten. Die Verbesserung umfasst soziale Determinanten der Gesundheit (SDoH) und Sterblichkeitsdaten, die tiefere Forschungsinsights ermöglichen.
Die Integration geht die Herausforderung an, dass 80% kritischer Patienteninformationen normalerweise in unstrukturierten Daten verschlossen sind. Mit fortschrittlicher Technologie zur Verarbeitung natürlicher Sprache (NLP) bietet VNEHR Daten nun forschungsbereite, anonymisierte Daten, die für Lebenswissenschaften, öffentliche Gesundheit und akademische Forschung optimiert sind.
Die neuen, aus NLP abgeleiteten SDoH-Daten umfassen sozioökonomische, Umwelt- und Verhaltensfaktoren wie Einkommensniveaus, Bildung, Wohnstabilität und soziale Unterstützung. Die Ergänzung der Sterblichkeitsdaten zielt darauf ab, die Generation von realen Beweisen zu verbessern, die Nachverfolgung nach dem Markteintritt zu unterstützen und die Arzneimittelentwicklung durch bessere Identifizierung von gefährdeten Bevölkerungsgruppen zu verbessern.
- Database expansion to include SDoH and mortality data enhances research capabilities
- Large patient database covering 154M unique patients nationally
- Advanced NLP technology unlocks previously inaccessible patient information
- Potential for improved revenue through enhanced life sciences research offerings
- None.
Veradigm Network EHR (VNEHR) Data includes over 154M unique patients nationally, transforming research capabilities and advancing patient care
Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced the integration of two new datasets to expand the depth and breadth of Veradigm Network EHR (VNEHR) Data, one of the nation’s most comprehensive ambulatory electronic health record (EHR) databases. The database enrichment includes social determinants of health (SDoH) and mortality data, giving researchers new insights to tackle health disparities, enhance real-world evidence (RWE) studies, improve care, and offer strategic and operational benefits for life science companies.
“With our NLP-derived SDoH and mortality data, life sciences organizations gain a competitive advantage by moving beyond traditional clinical measures to explore the full spectrum of factors influencing patient health,” said Stuart Green, Vice President & General Manager of Life Sciences Business for Veradigm. “This innovation unlocks new research opportunities and can position organizations as leaders in advancing health equity and improving patient outcomes.”
Currently,
The new NLP-derived SDoH data within VNEHR Data provides researchers with insights into socioeconomic, environmental and behavioral factors, including income levels, education, housing stability, and social support, areas that can be overlooked in traditional clinical data. By extracting nuanced SDoH information, Veradigm is enabling researchers to take a more holistic view of the patient and explore the intersection of clinical and social factors influencing health outcomes. This will help life science organizations enhance treatment insights, advance evidence generation, support market access strategies, and refine patient segmentation.
In addition, ambulatory EHR mortality data provides researchers with meaningful insights into patient populations and associated outcomes within outpatient care settings. This foundational dataset helps life science organizations enhance RWE generation by demonstrating long-term safety and efficacy and supporting post-market surveillance by identifying mortality trends associated with drug or device use. Additional benefits include accelerating drug development through improved identification of patient populations at risk, demonstrating value to payers and providers through added evidence to support reimbursement decisions, and enhancing precision medicine efforts by combining mortality data with genetic and biomarker information.
About Veradigm®
Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.
© 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113137490/en/
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@veradigm.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com
Source: Veradigm
FAQ
What new datasets did Veradigm (MDRX) add to its EHR database?
How many unique patients does Veradigm's (MDRX) VNEHR database cover?
What percentage of critical patient information does Veradigm (MDRX) unlock with its NLP technology?
What types of SDoH data does Veradigm (MDRX) now track in its database?
How will the new mortality data benefit Veradigm's (MDRX) life science customers?
